Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices
Crossref DOI link: https://doi.org/10.1007/s11060-015-1752-y
Published Online: 2015-03-15
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Clara
Ravelo, Arliene
Yu, Elaine
Dhanda, Rahul
Schnadig, Ian
License valid from 2015-03-15